1-iodo-3-phenylpropan 4119-41-9 Fingolimod intermediate
4119-41-9
shanghai
1kg/bag
2023-03-03
calcium L-5-methyltetrahydrofolate
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
1-IODO-3-PHENYLPROPANE
Other Name:Hydrocinnamyliodide;(1-iodopropyl)benzene;4-n-Propyliodobenzene;3-Phenylpropyliodide;(3-Iodopropyl)benzene;1-Phenyl-3-iodopropane;1-Iodo-3-phenylpropane97%;3-Iodo-1-phenylpropane,97%
CAS No.:4119-41-9
Molecular Formula:C9H11I
InChIKeys:RGCKJSPKMTWLLX-UHFFFAOYSA-N
Molecular Weight:246.08800
Exact Mass:245.99100
DSSTox ID:DTXSID00194110
HScode:2903999090
Categories:
Characteristics-
PSA:
0
XLogP3:3.05420
Density:1.561g/cm3
Melting Point:54-56 °C(Solv: ethyl acetate (141-78-6); ethyl ether (60-29-7))
Boiling Point:248ºC at 760mmHg
Flash Point:104.9ºC
Refractive Index:n20/D 1.5820(lit.)
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
calcium L-5-methyltetrahydrofolate
-
Location:
No.111,Qinxin Rd,Donggang Town,Xishan Dist,Wuxi,China.
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A
-
Average lead Time:
300
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
101-200
-
Year of Establishment:
2004
-
Certifications:
KOSEHR
Wuxi Taxus Pharmaceutical Co.,Ltd was established in 2004,and a bio-pharmaceutical company under the HODO Group which is the top 500 private enterprises . It is mainly engaged in the research, development, production and sales of paclitaxel-based anti-tumor drugs. The complete industrial chain was established,from the cultivation of yew resources to the processing of yew branches and leaves, paclitaxel primary products, paclitaxel series of raw materials and intermediates to preparations . Products include paclitaxel, docetaxel, cabazitaxel, 10-DAB, oxaliplatin, dresian hydrochloride, allopurinol, L-5-methylfolate, L-5-methylfolate, etc. API, and paclitaxel injection.
The company has strong technical strength. In 2018, the company established the Hongdoushan International Pharmaceutical Research and Development Company in New York, focusing on the research and development and introduction of anticancer drugs. At present, the Hongdoushan research and development center hires the Doctor returned from abroad to lead the research and development of new products, and currently has more than 30 senior engineers. What’s more, the R&D Center has established close cooperative relations with Jiangsu Academy of Agricultural Sciences, Beijing Institute of Materia Medica, Chinese Academy of Medical Sciences, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Tsinghua University, and foreign research institutes.
The company's paclitaxel API has obtained the US DMF registration number (25759), and is registered in Korea, India, Iran, Russia, Belarus and other countries. It is sold at home and abroad, mainly exported to India, South America, Russia, Egypt and other countries and regions,and praised
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product